Alpha Tau Medical announces annual shareholder meeting notice and proxy statement

• Alpha Tau Medical will hold its annual general meeting of shareholders in Jerusalem on June 23, 2026.
• Shareholders will vote on the re-election of David Milch and Ruth Alon as Class II directors, with terms running through the 2029 annual meeting.
• The agenda also includes a refreshed executive and director compensation policy, continued combined CEO-chairman roles for Uzi Sofer, and a new compensation package for Sofer.
• Other items include authorizing extensions of certain outstanding options for directors and officers, with extensions of up to 10 years from expiry.
• Shareholders will also vote on reappointing Kost Forer Gabbay & Kasierer, an Ernst & Young Global member firm, as independent auditor for the year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-058484), on May 18, 2026, and is solely responsible for the information contained therein.